RSS

antivirals

Antiviral drug discovery and development company, ReViral, has successfully completed its Series B financing round, raising $55 million in funding. Read more

News

Roche has revealed the results of its Phase III CAPSTONE-2 study in which its investigational oral, single-dose antiviral, baloxavir marboxil, has shown superior efficacy in the primary endpoint of time to improvement of flu symptoms versus placebo. Read more

News

Biotechnology company, VirionHealth, has raised series A funding of up to £13 million from an international investment group dedicated to the life sciences, Abingworth. Read more

News